NEW CARBORANE-BASED COMPOUNDS FOR BORON NEUTRON-CAPTURE THERAPY - BINDING AND TOXICITY OF ANC-1, DAC-1 AND B-ET-11-OME IN CULTURED HUMAN GLIOMA AND MOUSE MELANOMA-CELLS
P. Lindstrom et al., NEW CARBORANE-BASED COMPOUNDS FOR BORON NEUTRON-CAPTURE THERAPY - BINDING AND TOXICITY OF ANC-1, DAC-1 AND B-ET-11-OME IN CULTURED HUMAN GLIOMA AND MOUSE MELANOMA-CELLS, Anti-cancer drugs, 5(1), 1994, pp. 43-52
The toxicity and binding of the three new carborane based compounds: 2
(1,2-dicarba-closo-dodecaborane (-yl-methoxy)-2-(3-amino-propyl))-1,3
-propanediol, called DAC-1; 7-(3-amino-propyl)-7,8-dicarba-nido-undeca
rborate (-1) called ANC-1; and rboranyl)-nonyl-2-methyl-glycero-3-phos
phocholine, called B-Et-11-OMe, were analyzed with cultured human glio
ma cells, U-343MGa, and mouse melanoma cells, B16, as biological model
s. The previously developed compound di-sodium undecahydro-mercapto-cl
oso-dodecarborate (BSH), which is tested for therapy of malignant glio
mas, was analyzed for comparison. In the toxicity tests the cells were
exposed to the substances at cell culture medium concentrations in th
e range 0-50 ppm boron for 1 or 20 h and thereafter analyzed regarding
growth. Growth-disturbing effects were seen for the two compounds DAC
-1 and B-Et-11-OMe at the concentrations corresponding to 15 and 50 pp
m boron, respectively. The compounds ANC-1 and BSH showed no growth-di
sturbing effects at the tested concentrations. In the binding tests, t
he cells were incubated for 20 h at about the highest compound concent
rations that did not cause growth disturbances. The boron content in t
he cells was then determined by inductively coupled plasma-atomic emis
sion spectrometry (ICP-AES) and in some cases ICP-mass spectrometry (I
CP-MS). The most extensive binding was seen for DAC-1 and B-Et-11-OMe,
which accumulated boron to about 100 and 60 times, respectively, comp
ared with the concentration in the culture medium. The compound ANC-1
also accumulated boron in the cells but the boron could be easily wash
ed out indicating no or only a weak binding. BSH did not accumulate. F
urther analysis should be made regarding biological properties such as
intracellular compartmentalization, metabolic interference and tumor
specificity of the compounds DAC-1 and B-Et-11-OMe.